Wang Kuan Ying, Hsu Kuei Chang, Liu Wen Chung, Yang Kuo Chang, Chen Lee Wei
Ann Plast Surg. 2018 Feb;80(2S Suppl 1):S84-S86. doi: 10.1097/SAP.0000000000001310.
Xanthelasma palpebrarum is a common periorbital lesion that occurs in middle-aged woman. Dyslipidemia was strongly associated with the occurrence of xanthelasma. Different treatment methods for xanthelasma were applied with comparable results.
This was a retrospective chart review series performed at a single institute. The surgical pathology of 69 patients who received surgical excision from 1994 to 2012 was obtained. In addition, International Classification of Diseases, Ninth Revision, Clinical Modification code of xanthelasma (374.51) of 44 patients who underwent nonsurgical treatment at an outpatient department was acquired from 2006 to 2012. The serum lipid levels, comorbidities, recurrence, and treatment methods were obtained and analyzed with Statistical Analysis System (SAS) 9.4.
Of a total of 113 identified patients, 50 had lipid profile data. Of these 50 patients, 25 (50%) had dyslipidemia, which is higher than general population in Taiwan. The recurrence rate was 17.5%, and there was no statistical difference in the recurrence rate between the different treatment methods.
Xanthelasma was found to be associated with dyslipidemia. Thus, we recommend patients with xanthelasma to check their lipid profile and receive diet control and lipid-lowering medications for lipid abnormalities.
睑黄瘤是一种常见的眶周病变,好发于中年女性。血脂异常与睑黄瘤的发生密切相关。针对睑黄瘤应用了不同的治疗方法,效果相当。
这是一项在单一机构进行的回顾性病历审查系列研究。获取了1994年至2012年接受手术切除的69例患者的手术病理资料。此外,还从2006年至2012年获取了44例在门诊接受非手术治疗的患者的睑黄瘤国际疾病分类第九版临床修订编码(374.51)。利用统计分析系统(SAS)9.4获取并分析血清脂质水平、合并症、复发情况及治疗方法。
在总共113例确诊患者中,50例有血脂数据。在这50例患者中,25例(50%)存在血脂异常,高于台湾地区的一般人群。复发率为17.5%,不同治疗方法之间的复发率无统计学差异。
发现睑黄瘤与血脂异常有关。因此,我们建议睑黄瘤患者检查血脂情况,并针对脂质异常接受饮食控制和降脂药物治疗。